CapsoVision (CV)
Swallowable capsule imaging and video workflows for small-bowel examinations.
Something off on this page? Send us feedback.
Sells single-use CapsoCam Plus capsules for small-bowel imaging alongside reading devices, cloud video delivery and video-reading services. Revenue is concentrated in the Capsule Endoscopy Segment, with direct U.S. sales and international distributor channels.
Builds the CapsoCam Plus system for small-bowel imaging: a swallowable, single-use capsule that captures a panoramic view, stores video internally, and avoids a body-worn recorder. CapsoCloud supplies U.S. workflow for tracking procedures, streaming video and managing exam data, while CapsoView supports local review where cloud deployment is constrained. Repeat sales of capsules are supplemented by reading devices, cloud delivery and video-reading services.
Sells directly to U.S. practices, clinics and hospitals, and reaches overseas markets primarily through exclusive distributors. Final testing, cleaning, packaging and labeling take place in Saratoga after component production and assembly in Asia. Commercial expansion depends on FDA review for the AI reading module and colon program, reimbursement and provider adoption, and single-source supply of key components.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $9.1M · Total debt $687.0K · Total assets $18.6M · Shareholders' equity $13.2M
- Revenue
- $3.6M
- Operating income
- −$7.6M
- Net income
- −$7.5M
No dividends on record.
| Institutions | 10.34% | 5.18M shares | |
|---|---|---|---|
| 52 holders · as of Jun 30, 2026 | |||
| Insiders | 24.74% | 12.38M shares | |
| 2 holders · as of Sep 18, 2026 | |||
| Strategic holders | 6.89% | 3.45M shares | |
| 1 holder · as of Nov 12, 2025 | |||
| Other | 58.03% | 29.04M shares | |
| remainder | |||
50.05M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Ching Hang Shen1Insider10 percent owner | 14.54% | 6.40M | filed Sep 18, 2026 |
Eliyahou HarariInsider | 10.19% | 5.10M | filed May 6, 2026 |
Kioxia CorporationStrategic | 6.89% | 3.45M | filed Nov 12, 2025 |
BlackRock, Inc.Institution | 3.79% | 1.90M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 2.11% | 1.06M | as of Jun 30, 2026 |
- Ching Hang Shen's transaction reports restate only vehicles that traded; the 2026 ownership statement (6.40M) plus the 878.7K net shares acquired since is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 15, 2026 | Ching Hang Shen | 10 percent owner | +878,734 | $5.69 |
